"TriciribinePTDCP50714" . "280594"^^ . . "FDA"^^ . "TriciribineSYDTPNSC0154020" . "3-amino-1, 5-dihydro-5-methyl-1-.beta.-D-ribofuranosyl-1,4,5,6, 8-pentaazaacenaphthylene 5'-(dihydrogen phosphate)SNNCI" . . "1,4,5,6, 8-Pentaazaacenaphthalen-3-amine, 1, 5-dihydro-5-methyl-1-(5-O-phosphono-.beta.-D-ribofuranosyl)-SYDTPNSC0280594" . "3-Amino-1, 5-dihydro-5-methyl-1-.beta.-D-ribofuranosyl-1,4,5,6, 8-pentaazaacenaphthylene 5'-(dihydrogen phosphate)SYDTPNSC0280594" . "Nucleic Acid, Nucleoside, or Nucleotide"^^ . "The phosphate salt of the synthetic, cell-permeable tricyclic nucleoside triciribine with potential antineoplastic activity. Triciribine inhibits the phosphorylation, activation, and signalling of Akt-1, -2, and -3, which may result in the inhibition of Akt-expressing tumor cell proliferation. Akts are anti-apoptotic serine/threonine-specific protein kinases that phosphorylate and inactivate components of the apoptotic machinery, including Bcl-xL/Bcl-2-associated death promoter (BAD) and caspase 9.NCI" . "TriciribineSYNCI" . "Triciribine PhosphatePTNCI" . "39723"^^ . "1,4, 5,6,8-Pentaazaacenaphthylen-3-amine, 1, 5-dihydro-5-methyl-1-(5-O-phosphono-.beta.-D-ribofuranosyl)- (9CI)SYDTPNSC0280594" . "Tricyclic Nucleoside 5'-PhosphateSNNCI" . "Tricycloside PhosphateSYNCI" . "1,4,5,6, 8-pentaazaacenaphthalen-3-amine, 1, 5-dihydro-5-methyl-1-(5-O-phosphono-.beta.-D-ribofuranosyl)SNNCI" . . "Triciribine_Phosphate"^^ . "39723"^^ . "C0077070"^^ . . "1, 5-Dihydro-5-methyl-1-(5-O-phosphono-.beta.-D-ribofuranosyl)-1,4,5, 6,8-pentaazaacenaphthylen-3-amineSYDTPNSC0280594" . "61966-08-3"^^ . "C13H17N6O7P"^^ . "Pharmacologic Substance"^^ . "Triciribine Phosphate"^^ . "1,4, 5,6,8-pentaazaacenaphthylen-3-amine, 1, 5-dihydro-5-methyl-1-(5-O-phosphono-.beta.-D-ribofuranosyl)- (9CI)SNNCI" . "5L5GE3DV88"^^ . . "C1262"^^ . "TRICIRIBINE PHOSPHATEPTFDA5L5GE3DV88" . . "TCNABNCI" . "1, 5-dihydro-5-methyl-1-(5-O-phosphono-.beta.-D-ribofuranosyl)-1,4,5, 6,8-pentaazaacenaphthylen-3-amineSNNCI" . "Triciribine Phosphate"^^ .